text:
Q: Activating windows virtual machines for testing? good/bad? I am being asked to set up a battery of windows 7 flavours for a guy over in QA using VM's so that his office isn't filled with boxen. Is the common practice to activate these temporary machines or do folks just set them up, run the tests and then reload after a while.
Does this even matter?

A: I've been testing it on a machine and I don't bother to activate as I usually rebuild that machine every other week to test something else. If you plan to use those VM for longer than the period before activation I'd say yes, activate them.

A: Depends on your exact needs, but you should have a standardized Virtual Machine, activated or not, then make a fresh copy and run the tests when you need to.

A: I don't know about Win7, but we're gold partners and while we get 500 licenses for Vista Business/Enterprise, we get 1 license for Vista Ultimate. Activating that on test virtuals burned that single lincense for us, and we have to call to get it activated.

A: This will absolutely depend on your license agreement.  We have extremely flexible licensing for testing/development purposes, which is exactly what you're doing.  Our desktop license count has proven to be effectively unlimited, as we simply get a new key whenever the old ones are used up by the constant VM churn.
Someone enlighten me if I'm mistaken, but there's nothing shady at all about installing and using a copy until the activation runs out.  No need to borrow trouble if the VMs won't be in QA long enough to explode.

A: If you're using test or development licenses (such as those bundled with TechNet or MSDN subscriptions), I would suggest not activating the installation unless you specifically need to use the test server beyond the evaluation period. The main reason is that Microsoft usually does not allow reactivation of used TechNet or MSDN licenses. [Edited based on comment]
If you are using regular retail licenses, this is less of an issue, except that activating the new machine will likely involve a call to Microsoft to document the license transfer.
The following option probably does not apply to you, but it's worth mentioning for the benefit of others: If you are using volume licenses, then activation is not ever necessary, but you should let your license administrator know of the change, so that your organization remains in compliance with the terms of the volume license agreement.

A: If these VM's are only going to exist a few weeks, I wouldn't bother activiating.  The system will run frin for 30 days without activation.
If you are testing for more than 30 days you can extend your 30 day count-down up to three times with this command:
slmgr -rearm

This must be run from an elevated prompt, requires a restart afterward, and does not violate the EULA.
However, if you're going to take these VM's offline for awhile and come back to them later I highly recomend activating.  Turning on a VM after 6 months that's deactivated because the grace period has experied is a huge annoyance.


It is actually an offence for anything other than a push bike to stop inside the green box at lights; here in Wellington I've seen folks in cars and motorbikes get a $175 fine for being there. A bit harsh maybe but that, apparently, is the law.
Whilst we're at it I can attest that Wellington car drivers are good with bikes; I go up and down Brooklyn Hill every day. Some of the best drivers are lorry and truck drivers (thank god). I always wave my thanks when cars and trucks are considerate, I like to think this is driving their behaviour (pun intended).
"Car drivers" (whatever that actually means) should welcome more cyclists as every cycle is one car less, so they can dash off to their next traffic jam all the quicker.
pity he doesn't work for TV3; we would have been spared their top story at 6 last night which involved Valerie Adams selling her latest book for five minutes.
Until yer average voter looses their government and media maintained fear of "drugs"; and politicians realise that, as butch as it sounds, you can't win a "War on Drugs" any more than you can poke fear in the eye there will be no progress out of this surreal situation.
Alcohol, it goes without saying, is the nastiest of all poisons we choose to use and yet people don't see it as a drug, nor as the massive problem it is.
And the main issue is why do humans want to get out of their trees, and what does this say about us, and how, if we agree we just gotta do it, can we do it as safely as possible?
I no longer take any drugs, bar coffee (hey, I live in Wellington, I believe it's illegal not to here), but I see nothing wrong in others so doing, unless they try driving or hitting each other (or me). I do object to my tax money being spent on nicking people for getting high, as shown on that superbly silly programme "Drugs Bust'.


The missive was aimed at helping retire more than $1 million in debt his federal campaign had amassed before he abandoned his run for president in September.
Assembly Minority Leader Peter Barca (D-Kenosha) said he wasn't buying it, noting Walker's low approval ratings as measured in polls by Marquette University Law School. He said Walker is simply trying to avoid being seen as a lame duck.
Obviously, Walker's presidential campaign fizzled so badly that it died in the crib long before a single voter went to an Iowa caucus. He had taken a lot of criticism for ignoring the needs of the state. Yet, precisely because his presidential ambitions hadn't amounted to anything, he suddenly lacked any obvious political future unless he ran for reelection. And the idea isn't all that far-fetched. Tommy Thompson served as Wisconsin's governor for 14 years and 28 days between 1987 and 2001.
Remember, too, that Walker cited the need for the party to unite around an opponent to Trump as one of his reasons for dropping out early. That's something that Trump remembers, and it's becoming an issue now as the Republicans get ready to vote in the Wisconsin primary.
"I'm all in" for Cruz, Walker said Tuesday.
Trump might be surprised about Walker's remaining strength in the Badger State, but according to Marquette University Law School's 2016 polling, 84% of Republicans still have a positive view of the governor.
Trump is trying to win the Wisconsin primary while repudiating his party's most influential figures here. He bragged Tuesday about crushing Walker's presidential bid. He accused him of sowing discord and starving the schools because he refused to raise taxes.
On that last point, the truth is relative.
A review of those federal data showed that Wisconsin's unemployment rate is at its lowest point since 2001 and that the state now has more than 2.9 million jobs, a figure it last reached in late 2007. But Wisconsin's job growth during Walker's tenure has lagged the national average and the fortunes of neighboring states.
This all raises the stakes in Wisconsin considerably. If Trump can come in there and trash the governor, trash the Speaker of the House, and basically trash Republican orthodoxy on taxes and entitlements, and come away with a win?
Needless to say, the whole Wisconsin establishment is arrayed against Trump, including their formidable phalanx of suburban talk radio hosts. As I said above, the governor does still enjoy a very healthy approval number among Republican voters. If they can't stop Trump, that will be a pretty strong indictment and a major show of weakness.
Even if they succeed in stopping Trump in the primary, unless he is prevented from being the nominee, it's going to be hard for them to unite behind their candidate in the general election.
If Ted Cruz somehow gets the nomination, Walker will have a future in his administration. Otherwise, he'll have to run for reelection or start shopping for a private sector job.
Yeah, I'd say that the stakes have gotten very high.


text:
Khuzdar's Shah Bilawal Noorani shrine: A journey of devotion
Qurban Ali KhushikPublished November 13, 2016
DawnNews
DADU: Shrouded in mystery and secrets of an ethereal world lies Lahoot Lamakan, a spiritual destination next to the shrine of Hazrat Bilawal Shah Noorani in the Wadh area of Khuzdar district.
Legend has it that this is where Hazrat Adam descended and where Hazrat Nuh's ark found solid ground to rest on. Hazrat Ali is said to have passed through here and Hazrat Shah Abdul Latif built a mosque here.
Each year in the month of Sha'aban, thousands of devotees make their way on foot across perilous terrain and seven mountains from Lal Baag in Sehwan to the Shah Bilawal Noorani shrine near Lahoot Lamakan. The devotees, known as Lahootis, rest at 14 destinations and spend a night at each of them. The journey of devotion must be completed within 14 nights.
Lahooti Asad Ali Rajput, a resident of Purano Chowk in Dadu city, has traversed the treacherous trail leading to the mystical destination five times so far. He shares the troubles and the spiritual gratification thousands of Lahootis embrace on their journey to the fabled shrine.
It starts with a meal at the kafi (enclosure) of Syed Hajan Shah Lakyari in Sehwan on Sha'aban 21, three days after the annual Urs of Hazrat Lal Shahbaz Qalandar. The devotees partake in langar of Lal Ji Kishti (langar, or shared meal) at this enclosure and make their way to Lal Bag, around 2km away from the shrine of Lal Shahbaz Qalandar.
Lal Bag is the first destination where all Lahootis gather and spend the night before they begin the pilgrimage. The second destination is the shrine of Sain Ali Raza Shah in Jhangara, around 6km away from Lal Bag, from where the pilgrims move to Panjtan Ja Chashma, the fabled spring. They spend a night there and move on to a shrine in Naing Sharif — the fourth destination. Syed Ghulam Shah Jilani, the caretaker of this shrine, Mr Rajput explains, is a sajadah nasheen of Shah Bilawal Noorani.
After spending a night at the shrine, the pilgrims make their way to Baga Shir, some 6km away from Naing Sharif. Here they cook food and spend the night before they make their way to the sixth and one of the most important destinations on their journey — Haoot cave. Legend has it that Hazrat Ali had crossed the cave and so it is obligatory for every Lahooti to spend the night and pay their respects here.
At the foot of the mountainous Bhit Jabal lies Shah Ja Kanda, where the terrain takes a treacherous turn, Mr Rajput says. The pilgrims have to watch their step here as they make their way to Noor Wahi, the eighth destination. Once there, Lahootis consider themselves blessed and lucky to have managed to cross the dangerous mountain path. At Noor Wahi, they rest and cook food with water from a fountain spring.
When he made the journey around five years ago, Mr Rajput recalls, almost 200 devotees had perished after consuming the spring water, which had turned poisonous. He was a part of the procession and believes himself blessed to have survived.
The ninth destination is the famous Chung Mountain from where pilgrims make their way to Har Mori, the tenth destination. Mai Ji Kandri is the 11th destination in the pilgrimage — the place is named after a woman who is said to have helped Lahootis find water and rations several centuries ago.
The terrain is almost entirely rocky and perilous by this point. Most pilgrims encounter death-defying moments and help each other make it to the other side.
The weary devotees find rest at the Dargah Syed Bahlool Shah Dewano where they spend the night and perform rituals before heading towards Shinh Lak (lion's crossing) where ritualistic mourning goes on throughout the night.
Finally, they reach the 14th destination — Khooi of Sarkar Shah Abdul Latif. Legend has it that the mystic had stayed here on his way to Lahoot Lamakan. He had dug a well and constructed a mosque — which stands to this day. The pilgrims say their prayers at the mosque before arriving at the Mohabbat Shah Faqir shrine. From here the journey to Dargah Shah Bilawal Noorani is smooth.
"It is only after a devotee spends the requisite 14 nights and pays respects at all these destinations can they call themselves a Lahooti," Mr Rajput explains. From here, the pilgrims are free to return home via local transport. Here is where the journey ends.
At least 52 killed, 102 injured in blast at Khuzdar shrine
Shrines under threat
For some a shrine, for others a refuge

redpajama_set_name: RedPajamaCommonCrawl


text:
Journal of Orthopaedic Case Reports » Jan - Feb 2018 | Volume 8 | Issue 1
Successful Treatment of Early Talar Osteonecrosis by Core Decompression Combined with Intraosseous Stem Cell Injection: A Case Report
[box type="bio"] Learning Point for this Article: [/box]
Osteonecrosis of the talus is a rare condition affecting fairly young people; MRI is the diagnostic method of choice, and core decompression with intraosseous stem cell injection provides a feasible treatment option for the early-stage talar osteonecrosis.
Case Report | Volume 8 | Issue 1 | JOCR Jan – Feb 2018 | Page 23-26| Mika T Nevalainen, Jussi P Repo, Maija Pesola, Jukka P Nyrhinen. DOI: 10.13107/jocr.2250-0685.982
Authors: Mika T Nevalainen[1],[3], Jussi P Repo[2], Maija Pesola[2], Jukka P Nyrhinen[2]
[1]Department of Radiology, Central Finland Central Hospital, Keskussairaalantie 19 Jyväskylä, 40620 Finland.
[2]Department of Orthopedics and Traumatology, Central Finland Central Hospital Keskussairaalantie 19, Jyväskylä, 40620 Finland.
[3]Medical Research Center, University of Oulu and Oulu University Hospital, P.O. Box 10, OYS 90029 Finland
Address of Correspondence:
Dr. Mika T Nevalainen,
Medical Research Center, University of Oulu and Oulu University Hospital, P.O. Box 10, OYS 90029 Finland.
E-mail: mika.nevalainen@oulu.fi
Introduction: Osteonecrosis of the talus is a fairly rare condition. Many predisposing factors have been identified including previous trauma, use of corticosteroids, alcoholism, and smoking. As a gold standard, magnetic resonance imaging (MRI) is the most sensitive and specific diagnostic examination to detect osteonecrosis. While many treatment options for talar osteonecrosis exist, core decompression is suggested on young patients with good outcome results. More recently, intraosseous stem cell and platelet-rich plasma (PRP) injection has been added to the core decompression procedure.
Case Report: We report a successful treatment of early talar osteonecrosis ARCO I (Association Research Circulation Osseous) by core decompression combined with stem cell and PRP injection. On 3-month and 15-month follow-up, MRI showed complete resolution of the osteonecrotic changes together with clinical improvement.
Conclusion: This modified technique is a viable treatment option for early talar osteonecrosis. Nevertheless, future prospects should include a study comparing this combined technique with plain core decompression.
Keywords: Core decompression, magnetic resonance imaging, osteonecrosis, stem cell, talus.
Talar osteonecrosis is a fairly uncommon entity caused by the disruption of the blood supply to the talus [1]. Talus is predisposed to osteonecrosis due to its unique anatomy, distinctive extraosseous arterial circulation, and variable intraosseous blood supply [1, 2]. Both traumatic and atraumatic causes behind the osteonecrosis of the talus have been identified. Traumatic causes constitute of 75% of the cases and involve talar fracture and dislocation of the talar neck [3]. Atraumatic causes generally include the use of corticosteroids, alcoholism, or smoking, but on some occasions also systemic lupus erythematosus, renal transplant, sickle cell anemia, and thrombophilias can lead to osteonecrosis [1]. Idiopathic cases of talar osteonecrosis have been described too. On radiographs, talar osteonecrosis can be seen as increased talar dome opacity (sclerosis) with surrounding radiolucent rim. Subsequent crescent subchondral lucency (crescent sign), deformity, and ultimately articular collapse are late manifestations of the talar osteonecrosis [1, 4, 5, 6]. Magnetic resonance imaging (MRI) is the superior imaging modality to detect osteonecrosis in early stages with sensitivity and specificity up to 99% [7]. On MRI, the typical initial findings consist of patchy bone marrow edema (increased signal on T2-weighted/fluid-sensitive sequences and decreased signal on T1-weighted images). Later, as radiographic sclerosis develops in the infarcted bone, corresponding low signal on both T1- and T2-weighted images can be detected. The reparative zone between necrotic tissue and viable granulation tissue represents the "double-line sign," a low-signal rim in which the inner aspect becomes high signal on T2-weighted images [4, 8]. Many classification systems for osteonecrosis exist, and the Association Research Circulation Osseous (ARCO) system was selected for this case report [9]. To the orthopedic surgeon, the osteonecrosis of the talus represents a dilemma; while several treatment options exist, the outcomes have remained suboptimal [10]. Moreover, while a plethora of treatment choices is available – including restricted weight-bearing, bracing, bone grafting, core decompression, talectomy, and arthrodesis – no consensus for the ideal treatment strategy for the talar osteonecrosis exists [10]. Here, we report a successful treatment of early osteonecrosis of the talus (ARCO Stage I) using core decompression combined with intraosseous stem cell and platelet-rich plasma (PRP) injection. This technique has been introduced by Hernigou and Beaujean mainly to treat osteonecrosis of the femoral head [11]. To the best of our knowledge, no prior literature exists where this modified technique had been used to treat talar osteonecrosis.
A 45-year-old man (treated from 11/2014 to 06/2016) with hypertension and hypothyroidism medications had twisted his right ankle while walking his dog. Primarily, he presented edema around the lateral malleolus, and no fracture was detected on radiographs (figure not shown); thus, conservative treatment with ankle brace was initiated. The pain in the ankle persisted for 3 months, and subsequent follow-up radiographs, and eventually MRI of the ankle was performed.
The radiographs were normal (Fig. 1a),but the MRI revealed ARCO Stage I osteonecrosis of the talus with increased signal on T2-weighted fat-saturated images and decreased signal on T1-weighted images; an additional minor crescent sign was also present (Fig. 2a and b). Due to the persisting pain and poor strain tolerance, core decompression with stem cell and PRP injection was performed using GPS® III (Gravitational Platelet Separation System; Zimmer-Biomet, Warsaw, Indiana, USA) and BioCUE BMA (Bone Marrow Aspirate [BMA] Concentration System; Zimmer-Biomet, Warsaw, Indiana, USA) systems. First, 30 ml of venous blood (including 3 ml of anticoagulant) was collected from the patient and centrifuged for 15 min. Accordingly, 3 ml of PRP was recovered from the centrifuged sample. In operating room under general anesthesia, autologous aspiration of bone marrow-derived stem cells from the right anterior iliac crest was carried out by an orthopedic surgeon. In total, 60 ml of BMA was collected and subsequently centrifuged for 15 min producing 6 ml of concentrated BMA. Finally, the PRP and BMA were mixed producing a total of 9 ml of the injectate. A stab incision on the anteroinferior edge of the medial malleolus was performed, and on fluoroscopic control, a guidance spike was directed into the talus to the region of the osteonecrosis. A 2.7 mm cannulated drill was used to provide core decompression. Routine histopathological specimens were not produced due to typical findings of osteonecrosis on MRI. Next, the PRP-BMA concoction was injected into the osteonecrotic region under fluoroscopic control using a 3 mm aspiration needle (Fig. 3). The incision wound was closed and full weight-bearing was restricted for 4 weeks with free mobilization of the ankle. On 4-week clinical follow-up, the patient presented no pain in the right ankle. Radiographs were normal except for the low mineral density of the bones in general (Fig. 1b). On the 3-month follow-up, the patient had fully resumed to his daily activities and his ankle was symptomless. The MRI revealed virtually complete resolution of the talar osteonecrotic changes (Fig. 2c and d). On the subsequent 15-month follow-up, the patient presented no symptoms and the MRI scan (Fig. 2e and f) as well as the radiographs (Fig. 1c) were normal.
The talus is uncommonly affected by osteonecrosis with an unknown incidence. Core decompression has been suggested as an alternative for the treatment of non-traumatic osteonecrosis of the talus without collapse by decreasing intraosseous pressure and promoting revascularization [12]. A study by Mont et al. concluded that core decompression is a feasible method of treatment for symptomatic osteonecrosis of the talus before collapse; at 7-year follow-up, 14 of the 17 ankles treated by core decompression had excellent or good result [13]. Another study also supported core decompression in symptomatic atraumatic talar osteonecrosis before collapse by reporting fair to excellent results in 29 of 32 patients [14]. A more recent study by Marulanda et al. depicted 44 ankles treated with core decompression, out of which 40 (91%) displayed good to excellent clinical outcomes in 4-year follow-up [15]. Overall, 28% of patients experience radiologic progression of the osteonecrosis [13, 14, 15]. Moreover, Issa et al. reported in their study that out of 85 ankles treated by core decompression only 17% demonstrated disease progression [16]. According to a fairly recent systematic review by Gross et al., the recapitulation of these results is that core decompression is an appropriate procedure in patients with early and late stage osteonecrosis secondary to atraumatic etiologies. However, further research is warranted to evaluate the role of core decompression in the treatment of traumatic talar osteonecrosis [10]. In addition to normal core decompression, Hernigou and Beaujean have introduced a method combining core decompression with intraosseous stem cell and PRP injection in the treatment of osteonecrosis of the femoral head [11]. Furthermore, two recent meta-analyses by Papakostidis et al. and Piuzzi et al. showed that on early-stage osteonecrosis of the femoral head the combined approach improves patients' prognosis when compared to plain core decompression [17, 18]. Here, we have described a case with successful treatment of ARCO Stage I talar osteonecrosis using this combined technique. Initially, the patient presented a minor ankle sprain with persisting pain. The radiographs showed no diagnostic findings, and after definitive MRI diagnosis for early talar osteonecrosis, core decompression with stem cell and PRP injection was performed. Due to the typical MRI appearance of osteonecrosis, histopathological samples were not routinely collected. The differential diagnosis on this case might include insufficiency fracture of the talus and transient bone marrow edema, but since persisting pain and the crescent sign seen on MRI, ARCO Stage I osteonecrosis represents the most plausible diagnosis. On follow-up visits, the patient was symptomless and MRI findings of the osteonecrosis were seen to resolve.
We conclude that this modified technique is a viable option in the treatment of early talar osteonecrosis; however, future prospects should include a study comparing this combined technique with plain core decompression.
Clinical Message
Talar osteonecrosis is a fairly rare entity; however, MRI usually yields a definitive diagnosis. Since osteonecrosis is a progressive disease, treatment options should be considered with haste. Core decompression combined with intraosseous stem cell injection offers a feasible therapy option for the early talar osteonecrosis.
1. Pearce DH, Mongiardi CN, Fornasier VL, Daniels TR. Avascular necrosis of the talus: A pictorial essay. Radiographics 2005;25:399-410.
2. Mulfinger GL, Trueta J. The blood supply of the talus. J Bone Joint Surg Br 1970;52:160-7.
3. Adelaar RS, Madrian JR. Avascular necrosis of the talus. Orthop Clin North Am 2004;35:383-95.
4. Murphey MD, Foreman KL, Klassen-Fischer MK, Fox MG, Chung EM, Kransdorf MJ. From the radiologic pathology archives imaging of osteonecrosis: Radiologic-pathologic correlation. Radiographics 2014;34:1003-28.
5. Solomon L. Mechanisms of idiopathic osteonecrosis. Orthop Clin North Am 1985;16:655-67.
6. Resnick D, Sweet DE, Madewell JE. Osteonecrosis: Pathogenesis, diagnostic techniques, specific situations, and complications. In: Diagnosis of Bone and Joint Disorders. 4th ed. Philadelphia, PA: Saunders; 2002. p. 3599-685.
7. Lieberman JR, Berry DJ, Mont MA, Aaron RK, Callaghan JJ, Rajadhyaksha AD, et al. Osteonecrosis of the hip: Management in the 21st century. Instr Course Lect 2003;52:337-55.
8. Buchan CA, Pearce DH, Lau J, White LM. Imaging of postoperative avascular necrosis of the ankle and foot. Semin Musculoskelet Radiol 2012;16:192-204.
9. Mont MA, Marulanda GA, Jones LC, Saleh KJ, Gordon N, Hungerford DS, et al. Systematic analysis of classification systems for osteonecrosis of the femoral head. J Bone Joint Surg Am 2006;88 Suppl 3:16-26.
10. Gross CE, Haughom B, Chahal J, Holmes GB Jr. Treatments for avascular necrosis of the talus: A systematic review. Foot Ankle Spec 2014;7:387-97.
11. Hernigou P, Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res 2002;405:14-23.
12. Léduc S, Clare MP, Laflamme GY, Walling AK. Posttraumatic avascular necrosis of the talus. Foot Ankle Clin 2008;13:753-65.
13. Mont MA, Schon LC, Hungerford MW, Hungerford DS. Avascular necrosis of the talus treated by core decompression. J Bone Joint Surg Am 1996;78:827-30.
14. Delanois RE, Mont MA, Yoon TR, Mizell M, Hungerford DS. Atraumatic osteonecrosis of the talus. J Bone Joint Surg Am 1998;80:529-36.
15. Marulanda GA, McGrath MS, Ulrich SD, Seyler TM, Delanois RE, Mont MA, et al. Percutaneous drilling for the treatment of atraumatic osteonecrosis of the ankle. J Foot Ankle Surg 2010;49:20-4.
16. Issa K, Naziri Q, Kapadia BH, Lamm BM, Jones LC, Mont MA, et al. Clinical characteristics of early-stage osteonecrosis of the ankle and treatment outcomes. J Bone Joint Surg Am 2014;96:e73.
17. Papakostidis C, Tosounidis TH, Jones E, Giannoudis PV. The role of "cell therapy" in osteonecrosis of the femoral head. A systematic review of the literature and meta-analysis of 7 studies. Acta Orthop 2016;87:72-8.
18. Piuzzi NS, Chahla J, Schrock JB, LaPrade RF, Pascual-Garrido C, Mont MA, et al. Evidence for the use of cell-based therapy for the treatment of osteonecrosis of the femoral head: A Systematic review of the literature. J Arthroplasty 2017;32:1698-708.
Dr. Mika T Nevalainen Dr. Jussi P Repo Dr. Maija Pesola Dr. Jukka P Nyrhinen
How to Cite This Article: Nevalainen M. T, Repo J. P, Pesola M, Nyrhinen J. P. Successful Treatment of Early Talar Osteonecrosis by Core Decompression Combined with Intraosseous Stem Cell Injection: A Case Report. Journal of Orthopaedic Case Reports 2018 Jan-Feb; 8(1): 23-26.
[Full Text HTML] [Full Text PDF] [XML]
[rate_this_page]
Dear Reader, We are very excited about New Features in JOCR. Please do let us know what you think by Clicking on the Sliding "Feedback Form" button on the <<< left of the page or sending a mail to us at editor.jocr@gmail.com
Unusual Presentation of Tuberculosis of… Previous Article Impalement Injury to Thigh: A… Next Article
Giant Cell Tumor of Talus – A Case Report...
A Reminder for Chronic Ankle Pain: Case Report of Talar Osteoid Osteoma with Late Diagnosis...
A Rare Cause of Ankle Pain – Chondrosarcoma of the Talus: A Case Report and Literature Review...
Open Treatment of Closed Talus Dislocation without Fracture: A Case Report and Literature Review...


text:
Q: Java applet won't load JAR from local machine on any browser I have looked on the web and found similar questions on SO but none are helping me. I need to test an HTML page containing an applet on my local machine and it just won't work.
My HTML looks like this:
applet.innerHTML = ' \
    <applet id="applet" code="pulpcore.platform.applet.CoreApplet" codebase="." width="800" height="600"> \
        <param name="archive" value="test.jar"> \
        <param name="codebase_lookup" value="false"> \
        <param name="cache_option" value="Plugin"> \
        \
        <param name="separate_jvm" value="true"> \
        <param name="java_arguments" value="-Xms150M -Xmx700M -Djnlp.packEnabled=false -Dsun.java2d.noddraw=true -Dsun.awt.noerasebackground=true -Dsun.java2d.d3d=false -Dsun.java2d.opengl=false -Dsun.java2d.pmoffscreen=false"> \
        \
    </applet>';

The JAR file is in the same dir as the HTML file so I think codebase="." is right... I tried codebase="file:///." with no luck either.
I thought I had it working in Chrome (on Windows 7) but then I get this message:

On IE10 and FF it just fails immediately. Applets/web-dev aren't my specialities, I'm a java guy just testing the functionality of the applet before deploying. The applet is built into a local dir by an Ant script so I don't really want to go copying it to another dir so it can be hosted locally. I have to go that route I think IIS7 is already running on my PC so that's my preference... but this definitely used to work.
Oh - and I am running the latest version of Chrome (updated today).

redpajama_set_name: RedPajamaStackExchange


According to the EU's Waste Framework Directive, waste prevention should be the first priority of waste management, while re-use and material recycling should be preferred to energy recovery from waste. A cruise ship is like a small town and, given the degree of luxury afforded passengers on cruise ships, per capita waste production is even higher. The amount of waste generated is 70 times more than a typical cargo ship. Cruise ships represent less than 1% of the global merchant fleet yet it has been estimated that they are responsible for 25% of all waste generated by merchant vessels. In accordance with EU Directive 2000/59, Article 4(2), it is clear that any home port or port of call for cruise ships should provide adequate waste management facilities to cope with the volume of waste generated by these vessels. Nonetheless, onboard and onshore waste management has never been tackled from a recycling perspective, nor is it regulated by an EU Directive or national laws, and an integration of the Kyoto requirements in the marine sector is still missing.
The Sustainable Cruise project aims to demonstrate the potential for waste prevention, recovery and recycling on a cruise ship, focusing on the detection, testing, evaluation and dissemination of best available techniques and approaches for three on-board waste streams: (i) packaging; (ii) biodegradable waste; and (iii) paper; and three horizontal issues: (i) energy efficiency; (ii) onshore rubbish disposal; and (iii) normative consistency and pre-certification.
The project will identify and assess the environmental impacts (through a lifecycle assessment - LCA - methodology) and the technical and economic viability of the large-scale introduction of promising solutions for the prevention, recovery and recycling of onboard packaging, biodegradable and paper waste. The project will also draft first suggestions for a standardised approach to waste management on-board, applying for the first time the Kyoto requirements in the marine sector. The project will work with this approach in order to test advanced solutions for waste management and provide guidelines for a standard process. It will provide guidelines for an advanced certification scheme and assess some additional criteria in order to verify the possibility of converting CO2 emissions reductions into tradeable carbon credits.
A set of guidelines for waste prevention, recovery and recycling.
Description Costa Crociere SpA is the largest Italian travel group and Europe's largest cruise company, comprising the brands Costa Cruises, AIDA Cruises and Iberocruceros. The Group is headquartered in Genoa, and has a fleet of 25 ships with a total guest capacity of some 60 000 people.


When it comes to starting a new company there is a lot of paperwork to complete before your business is fully up and running. Along with bookkeeping, taxes and annual accounts; we can also help with the initial organisation and setup of your company. At 123 Accountancy Services on the Isle of Man, we can help to start you company and file all of the correct paperwork with the Isle of Man Treasury, Financial Services Authority and Customs and Excise. Additionally, we can help your company plot an outline of expected profits over the year, and plan ahead financially.
Starting up a new company can be an exciting and daunting process, and requires a lot of knowhow in regards to how companies must file and process their financial records. New companies also often require external funding in order to get on their feet, and whether this is a small loan from a loans company, or off of friends and family; it is important to make sure that you have a plan in place to pay back the money owed. This can include working out how much money it will cost to run your business (tools, equipment, wages, bills and many other things need to be taken into account), and how much your company would need to make in order to turn a profit and pay off the loan within the agreed time.
123 Accountancy Services can help your company avoid some of the major potholes that new businesses often face.
If you are looking for a professional accountant to help advise on the many challenges that you face as a start-up company on the Isle of Man, then look no further than 123 Accountancy Services. Give us a call now on 07624 423970, or send a message through the Contact Page.
Do you spend too much of your own time or your staffs time on bookkeeping when you could be focusing on your own business?
Your expertise doesn't lie with bookkeeping or accountancy so are you confident that everything is correct, accurate and up to date?
Would you like to hand over the bookkeeping and accountancy responsibilities to an expert, taking away your stress and leaving you comfortable in the knowledge that everything is taken care of?
If the answer to any of the questions above is yes then it makes sence to contact us on 07624 423970.


Project Components - Shelter - Aura Landscapers Ltd.
Children should spend their outdoor summer time both in and out of the sun. Gardeners often need to get out of the direct rays for a while too. Shelter provided by structures and trees can provide you with another means to "escape from it all".
Shelter should be planned as part of every yard design.


Tiling A Floor With Large Tiles In Impeccable A Bathroom For Full Size Then Walls Commercial Tile Plus A Bathroom Plus Walls Commercial Tile Tail Tile Large Size And Wallscommercial Bathroom Tiling A Bathroom Although Lovable Large Size Also Tile Layout Bathroom Ingshower Tile Bathroom Bathroom Bathroom Tile Layout Bathroom Ing Shower ~ Whiskeyyourway Deco Insp.
Impeccable a bathroom for full size then walls commercial tile plus a bathroom plus walls commercial tile tail tile large size and wallscommercial bathroom tiling a bathroom. Lovable large size also tile layout bathroom ingshower tile bathroom bathroom bathroom tile layout bathroom ing shower. Peculiar rd generation tiling wall tilers gillen tiling s gallery bathtub together with bathroom ideas. Tempting ing tile also shower installation grouting pan or new grout is likabl in shower tile kits tags 50 shower tile how to install a tile shower full size. Divine royalty free tiling photos also bathroom ideas as wells as tiling s gallery bathtub. Lummy kitchen tile design patterns decoration tiling a or kitchens spaces dish towels islands s decor hells quotes wall art curtains ideas des. Distinguished tiling d model obj fbx ma mb dae mtl tga d model tiling cgtrader. Lummy mosaic hex tiles did not want to stay and place and kept popping out. Adorable badly tiled how to not tile a bathroom kitchen wall tiles.
Impeccable a bathroom for full size then walls commercial tile plus a bathroom plus walls commercial tile tail tile large size and wallscommercial bathroom tiling a bathroom in tiling a floor.
Lovable large size also tile layout bathroom ingshower tile bathroom bathroom bathroom tile layout bathroom ing shower in tiling a floor.
Peculiar rd generation tiling wall tilers gillen tiling s gallery bathtub together with bathroom ideas in tiling a floor.
Tempting ing tile also shower installation grouting pan or new grout is likabl in shower tile kits tags 50 shower tile how to install a tile shower full size in tiling a floor.
Divine royalty free tiling photos also bathroom ideas as wells as tiling s gallery bathtub in tiling a floor.
Lummy kitchen tile design patterns decoration tiling a or kitchens spaces dish towels islands s decor hells quotes wall art curtains ideas des in tiling a floor.
Distinguished tiling d model obj fbx ma mb dae mtl tga d model tiling cgtrader in tiling a floor.
Lummy mosaic hex tiles did not want to stay and place and kept popping out in tiling a floor.
Adorable badly tiled how to not tile a bathroom kitchen wall tiles in tiling a floor.
Classy wall ideas bathroom trends as wells as bathroom tile for wall ideas bathroom tile in tiling a floor.


text:
Home » FDA Strengthens Warning on Fluoroquinolone Antibiotics
FDA Strengthens Warning on Fluoroquinolone Antibiotics
Warning Against Flouroquinolone Antibiotics. The warning label on fluoroquinolone antibiotics, which includes the brand names Levaquin, Cipro, and Avelox, has been revised. The U.S. Food and Drug Administration (FDA) points out that the risks outweigh the benefits in patients with acute sinusitis, acute bronchitis, and uncomplicated urinary tract infections (UTIs) who can be treated with other medications.
According to the safety alert, patients with these conditions should only be treated with fluoroquinolones if no alternative treatments are available.
The notification warns that, "fluoroquinolones when used systemically (i.e. tablets, capsules, and injectable) are associated with disabling and potentially permanent serious side effects that can occur together. These side effects can involve the tendons, muscles, joints, nerves, and central nervous system."
The FDA updated the label based on the findings of an internal safety review. The FDA previously updated the warning label on fluoroquinolones in 2013 to warn about the risk of peripheral neuropathy.
Side effects associated with fluoroquinolones may include tendon
Side effects associated with fluoroquinolones may include tendon, joint and muscle pain, a "pins and needs" tingling or pricking sensation, confusion and hallucinations. If patients taking the drugs experience these symptoms, the FDA advises them to contact their health care professionals.
Levaquin is a fluoroquinolone approved in 1996. It was named in over 3,400 lawsuits by 2010. In a 2012 interview with The New York Times, pharmacological epidemiologist Dr. Mahyar Etminan found "that the risk of suffering potentially blinding retinal detachment was nearly fivefold higher among current users of fluoroquinolones . . . and [there was] a significantly increased risk of acute kidney failure."
Levaquin was also the subject of a lawsuit filed against former FDA Commissioner Margaret Hamburg, alleging she conspired to ensure Levaquin was approved for personal financial gain. The lawsuit contends that she helped approve the drug because she and her husband had large stakes in J&J, which manufactured Levaquin. Allegedly, Levaquin has been linked to 5,000 deaths.
Need Legal Help Regarding Fluoroquinolone Antibiotics?
The personal injury attorneys at Parker Waichman LLP offer free, no-obligation case evaluations. For more information, fill out our online contact form or call 1-800-YOURLAWYER (1-800-968-7529).
A National Law Firm With Offices In:
New York | Brooklyn | Queens | Long Island | New Jersey | Florida
Call us at: 1-800-YOURLAWYER (800-968-7529) | Schedule your free consultation
Tagged With: Antibiotics, FDA, STRENGTHENS, warning


text:
Tull Suwannakit is a visual artist, children's book author and illustrator with background in animation and fine art. He began his artistic career as a set designer and sculptor for an independent animation studio in New York. His work has been exhibited both locally and internationally, including The National Museum, Szczecin in Poland and included as part of The Australian Children's Book Illustration Exhibition and Rights Catalogue in Bologna, Italy. | tullsuwannakit.net
Little Ellie
Grandma Bear
Nice to Meet You Too
Trumpeting To The Moonlight
Put That Record On
Sad, The Dog
Stanley's Playing the Trumpet!
The Little Stowaway


text:
1 Samuel 21-23
On April 2, 2016 April 1, 2016 By Oby BallingerIn Daily Bible
Good morning! Thank you for your reflections and feedback each day, particularly yesterday. It's great to see how this group continues to inspire and encourage each other in our reading together. Today's passage (1 Samuel 21-23) shows how the rivalry between Saul and David escalates into a near civil war, with deadly implications for other Israelites caught up in the conflict.
David is not altogether forthright in his approach to the priest Ahimelech in chapter 21, which proves to be the priest's downfall. : David instead says that he's on a secret mission for Saul and asks for the holy bread of the shrine. The "throwaway" line about Doeg the Edomite portends some future impact, but we're not told what. David also takes with him from Ahimelech's shrine the sword of Goliath. There's no greater symbol of strength and power, for him especially. Ironically, David goes from there to find shelter in Gath, a Philistine city, where he pretends to be a madman so he's not harassed, captured or killed. He then holes up in a cave at the start of 1 Samuel 22, and those who were troubled by poverty or discontent with Saul's reign join him there (along with his family). David shelters his parents with the Moabite king, and goes into hiding in the forest with those who accompany him.
Meanwhile, Saul hears of David's whereabouts and castigates his servants for not letting him know sooner. Doeg the Edomite reveals where he saw David last, so Saul summons Ahimelech and interrogates him. The priest does not know the enmity between David and Saul, yet this does not lead Saul to spare his life. When Saul's own guards will not kill Abimelech and the other priests, Doeg the Edomite follow's Saul's command. Think of other places in the Hebrew Bible where the Edomites get a bad name (they're presented as the distasteful descendants of Esau from Genesis), and here Doeg does the deed too dirty for honorable Israelite guards. He slays nearly a hundred prophets, plus all their family members and livestock. Ahimelech's son survives and brings word of the slaughter to David.
Chapter 23 describes a series of cat-and-mouse maneuvers between David and Saul, with Philistine marauders acting as supporting characters in the drama. First, David hears of the Philistine attack against Keilah and he goes to defend the city. The bold move (refusing to stay hidden) wins David the battle and secures provisions for his followers. But Saul makes plans to besiege David's forces in the city, and David hears from God that the townspeople will turn him over to Saul rather than defend the city with him. So David and his rebel forces escape into the wilderness, eluding Saul again. Jonathan joins David and starts to imagine a life together where David is king. Saul comes to chase David down in Ziph (with the help of local informants) and is very close to catching him, but then must go chase out the raiding Philistines again. It's enough to be the second act in a melodrama, and we wonder what will come next. (I'm rather surprised that I've never seen a movie presentation of this biblical era—seems like it would make for great cinema.) Nevertheless, the curtain drops at the end of today's passage with an implied sign: "To be continued…" Happy reading!
Read 1 Samuel 21-23.
Please join discussion of this passage at the Daily Bible Facebook group, or comment below. The passage for tomorrow is 1 Samuel 24-26. Thanks for reading!


OLMM makes a strong commitment to helping create sustainable building designs. We have taken a keen and active role in specifying structural systems and materials that minimize impact on our environment.
We have explored innovative ways of maximizing the use of recycled materials for our projects. For example, we researched and specified the use of high flyash content for the precast concrete piles for the Oakland International Airport Terminal 2 Expansion project. This assertion helped the project in seeking LEED certification. Our other notable LEED projects include the Folsom Dore & Plaza Apartments multiple housing complexes.